{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T04:42:29Z","timestamp":1768970549389,"version":"3.49.0"},"reference-count":67,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2013,11,26]],"date-time":"2013-11-26T00:00:00Z","timestamp":1385424000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2014,1]]},"abstract":"<jats:sec>\n            <jats:title\/>\n            <jats:p>Hepatitis E virus (HEV) infection (genotype 3) has been described in developed countries as a cause of chronic hepatitis in recipients of solid organ transplantation (SOT), with the first cases reported in 2008. Immunosuppression seems to play a major role in the pathogenesis of chronic infections. The current gold standard for the diagnosis of HEV infection is the detection of HEV RNA in serum, stools, or both. In liver transplant recipients, HEV infection is considered an uncommon disease; however, a high index of suspicion is needed for patients with graft hepatitis of an unclear etiology. Liver transplant recipients seem more likely to develop chronic HEV after an acute infection, and there is accelerated progression to advanced fibrosis and cirrhosis. A decrease in immunosuppression is considered the first line of treatment, and pegylated interferon can be considered the second line of treatment for liver transplant recipients. At the present time, there are not enough data to recommend treatment with ribavirin for adult liver transplant recipients, although this has been tried in other SOT populations. <jats:italic toggle=\"yes\">Liver Transpl 20:15\u201324, 2014<\/jats:italic>. \u00a9 2013 AASLD.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/lt.23764","type":"journal-article","created":{"date-parts":[[2013,10,12]],"date-time":"2013-10-12T02:43:20Z","timestamp":1381545800000},"page":"15-24","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":33,"title":["Hepatitis E infection in liver transplant recipients"],"prefix":"10.1097","volume":"20","author":[{"given":"Alberto","family":"Unzueta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Rakela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-4-20250124","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1056\/NEJMra1204512","article-title":"Hepatitis E.","volume":"367","author":"Hoofnagle","year":"2012","journal-title":"N Engl J Med"},{"key":"R2-4-20250124","doi-asserted-by":"crossref","first-page":"9059","DOI":"10.1128\/JVI.00593-10","article-title":"Release of genotype 1 hepatitis E virus from cultured hepatoma and polarized intestinal cells depends on open reading frame 3 protein and requires an intact PXXP motif.","volume":"84","author":"Emerson","year":"2010","journal-title":"J Virol"},{"key":"R3-4-20250124","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.virusres.2011.02.011","article-title":"Molecular virology of hepatitis E virus.","volume":"161","author":"Ahmad","year":"2011","journal-title":"Virus Res"},{"key":"R4-4-20250124","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S1473-3099(08)70255-X","article-title":"Hepatitis E: an emerging infection in developed countries.","volume":"8","author":"Dalton","year":"2008","journal-title":"Lancet Infect Dis"},{"key":"R5-4-20250124","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1002\/hep.24674","article-title":"Hepatitis E.","volume":"54","author":"Aggarwal","year":"2011","journal-title":"Hepatology"},{"key":"R6-4-20250124","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1016\/S0140-6736(11)61849-7","article-title":"Hepatitis E.","volume":"379","author":"Kamar","year":"2012","journal-title":"Lancet"},{"key":"R7-4-20250124","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.hepres.2005.01.008","article-title":"Acute hepatitis E of a man who consumed wild boar meat prior to the onset of illness in Nagasaki, Japan.","volume":"31","author":"Masuda","year":"2005","journal-title":"Hepatol Res"},{"key":"R8-4-20250124","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1007\/s00535-003-1359-5","article-title":"Epidemiological and clinical study of sporadic acute hepatitis E caused by indigenous strains of hepatitis E virus in Japan compared with acute hepatitis A.","volume":"39","author":"Sainokami","year":"2004","journal-title":"J Gastroenterol"},{"key":"R9-4-20250124","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.3201\/eid1712.110371","article-title":"Hepatitis E virus antibodies in blood donors, France.","volume":"17","author":"Mansuy","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"R10-4-20250124","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.virusres.2011.01.016","article-title":"From barnyard to food table: the omnipresence of hepatitis E virus and risk for zoonotic infection and food safety.","volume":"161","author":"Meng","year":"2011","journal-title":"Virus Res"},{"key":"R11-4-20250124","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/MOG.0b013e32835ff238","article-title":"Hepatitis E virus infection.","volume":"29","author":"Kamar","year":"2013","journal-title":"Curr Opin Gastroenterol"},{"key":"R12-4-20250124","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.3201\/eid1809.120241","article-title":"Hepatitis E, a vaccinepreventable cause of maternal deaths.","volume":"18","author":"Labrique","year":"2012","journal-title":"Emerg Infect Dis"},{"key":"R13-4-20250124","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1097\/MEG.0b013e3282f5195a","article-title":"Autochthonous hepatitis E in southwest England: natural history, complications and seasonal variation, and hepatitis E virus IgG seroprevalence in blood donors, the elderly and patients with chronic liver disease.","volume":"20","author":"Dalton","year":"2008","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R14-4-20250124","first-page":"121","article-title":"Chronic hepatitis E in liver transplant recipients: a significant clinical problem?","volume":"56","author":"Pischke","year":"2010","journal-title":"Minerva Gastroenterol Dietol"},{"key":"R15-4-20250124","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1017\/S0950268809990847","article-title":"Transmission routes and risk factors for autochthonous hepatitis E virus infection in Europe: a systematic review.","volume":"138","author":"Lewis","year":"2010","journal-title":"Epidemiol Infect"},{"key":"R16-4-20250124","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1086\/653943","article-title":"The two faces of hepatitis E virus.","volume":"51","author":"Teshale","year":"2010","journal-title":"Clin Infect Dis"},{"key":"R17-4-20250124","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1086\/599319","article-title":"Epidemiology of hepatitis E virus in the United States: results from the Third National Health and Nutrition Examination Survey, 19881994.","volume":"200","author":"Kuniholm","year":"2009","journal-title":"J Infect Dis"},{"key":"R18-4-20250124","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.transproceed.2012.08.020","article-title":"Hepatitis E virus infection in a liver transplant recipient in the United States: a case report.","volume":"45","author":"Te","year":"2013","journal-title":"Transplant Proc"},{"key":"R19-4-20250124","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1017\/S0950268807008941","article-title":"Bayesian estimation of hepatitis E virus seroprevalence for populations with different exposure levels to swine in the Netherlands.","volume":"136","author":"Bouwknegt","year":"2008","journal-title":"Epidemiol Infect"},{"key":"R20-4-20250124","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3201\/eid1701.100527","article-title":"Hepatitis E virus infection without reactivation in solidorgan transplant recipients, France.","volume":"17","author":"LegrandAbravanel","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"R21-4-20250124","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3201\/eid1902.120961","article-title":"Laboratorybased surveillance for hepatitis E virus infection, United States, 20052012.","volume":"19","author":"Drobeniuc","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"R22-4-20250124","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1086\/655899","article-title":"Characteristics of autochthonous hepatitis E virus infection in solidorgan transplant recipients in France.","volume":"202","author":"LegrandAbravanel","year":"2010","journal-title":"J Infect Dis"},{"key":"R23-4-20250124","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jhep.2010.06.017","article-title":"Hepatitis E in Italy: a longterm prospective study.","volume":"54","author":"Romano","year":"2011","journal-title":"J Hepatol"},{"key":"R24-4-20250124","doi-asserted-by":"crossref","first-page":"20550","DOI":"10.2807\/1560-7917.ES2013.18.31.20550","article-title":"Silent hepatitis E virus infection in Dutch blood donors, 2011 to 2012.","volume":"18","author":"Slot","year":"2013","journal-title":"Euro Surveill"},{"key":"R25-4-20250124","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/jmv.21656","article-title":"A comparison of two commercially available antiHEV IgG kits and a reevaluation of antiHEV IgG seroprevalence data in developed countries.","volume":"82","author":"Bendall","year":"2010","journal-title":"J Med Virol"},{"key":"R26-4-20250124","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jcv.2012.09.010","article-title":"Discrepancy between antihepatitis E virus immunoglobulin G prevalence assessed by two assays in kidney and liver transplant recipients.","volume":"56","author":"RossiTamisier","year":"2013","journal-title":"J Clin Virol"},{"key":"R27-4-20250124","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.jviromet.2007.07.014","article-title":"Universal detection of hepatitis E virus by two realtime PCR assays: TaqMan and PrimerProbe Energy Transfer.","volume":"146","author":"Gyarmati","year":"2007","journal-title":"J Virol Methods"},{"key":"R28-4-20250124","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jviromet.2005.07.004","article-title":"A broadly reactive onestep realtime RTPCR assay for rapid and sensitive detection of hepatitis E virus.","volume":"131","author":"Jothikumar","year":"2006","journal-title":"J Virol Methods"},{"key":"R29-4-20250124","doi-asserted-by":"crossref","first-page":"729","DOI":"10.3201\/eid1905.121845","article-title":"; for HEV Collaborative Study Group. World Health Organization international standard to harmonize assays for detection of hepatitis E virus RNA.","volume":"19","author":"Baylis","year":"2013","journal-title":"Emerg Infect Dis"},{"issue":"suppl 2","key":"R30-4-20250124","doi-asserted-by":"crossref","first-page":"S223","DOI":"10.1016\/S0168-8278(12)60576-5","article-title":"Evaluation of eight commercial hepatitis E virus specific IgM and IgG ELISA assays abstract.","volume":"56","author":"Pas","year":"2012","journal-title":"J Hepatol"},{"key":"R31-4-20250124","doi-asserted-by":"crossref","first-page":"E166","DOI":"10.1111\/tid.12096","article-title":"Hepatitis E virus infection in a liver transplant recipient: delayed diagnosis due to variable performance of serologic assays.","volume":"15","author":"Yoo","year":"2013","journal-title":"Transpl Infect Dis"},{"key":"R34-4-20250124","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1128\/JCM.02578-10","article-title":"; for HEV Collaborative Study Group. Standardization of hepatitis E virus (HEV) nucleic acid amplification techniquebased assays: an initial study to evaluate a panel of HEV strains and investigate laboratory performance.","volume":"49","author":"Baylis","year":"2011","journal-title":"J Clin Microbiol"},{"key":"R35-4-20250124","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1002\/hep.26158","article-title":"Hepatitis E masquerading as druginduced liver injury.","volume":"56","author":"Chen","year":"2012","journal-title":"Hepatology"},{"key":"R36-4-20250124","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1053\/j.gastro.2011.07.051","article-title":"; for DrugInduced Liver Injury Network (DILIN). Acute hepatitis E infection accounts for some cases of suspected druginduced liver injury.","volume":"141","author":"Davern","year":"2011","journal-title":"Gastroenterology"},{"key":"R37-4-20250124","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1111\/j.1365-2036.2007.03504.x","article-title":"The role of hepatitis E virus testing in druginduced liver injury.","volume":"26","author":"Dalton","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"R38-4-20250124","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.jhep.2006.09.016","article-title":"Hepatitis E virus (HEV) infection in patients with cirrhosis is associated with rapid decompensation and death.","volume":"46","author":"Kumar Acharya","year":"2007","journal-title":"J Hepatol"},{"key":"R39-4-20250124","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/j.1440-1746.2007.05205.x","article-title":"Subacute hepatic failure due to hepatitis E.","volume":"23","author":"Ramachandran","year":"2008","journal-title":"J Gastroenterol Hepatol"},{"key":"R40-4-20250124","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1365-2893.2007.00858.x","article-title":"Fulminant liver failure from acute autochthonous hepatitis E in France: description of seven patients with acute hepatitis E and encephalopathy.","volume":"14","author":"Peron","year":"2007","journal-title":"J Viral Hepat"},{"key":"R41-4-20250124","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1600-0676.1985.tb00244.x","article-title":"Acute viral hepatitis superimposed on alcoholic liver cirrhosis: clinical and histopathologic features.","volume":"5","author":"Feller","year":"1985","journal-title":"Liver"},{"key":"R42-4-20250124","first-page":"227","article-title":"Hepatitis A and B superimposed on chronic liver disease: vaccinepreventable diseases.","volume":"117","author":"Keeffe","year":"2006","journal-title":"Trans Am Clin Climatol Assoc"},{"key":"R43-4-20250124","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1056\/NEJMoa0706992","article-title":"Hepatitis E virus and chronic hepatitis in organtransplant recipients.","volume":"358","author":"Kamar","year":"2008","journal-title":"N Engl J Med"},{"key":"R44-4-20250124","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/lt.21480","article-title":"Chronic hepatitis E virus infection in liver transplant recipients.","volume":"14","author":"Haagsma","year":"2008","journal-title":"Liver Transpl"},{"key":"R45-4-20250124","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/lt.21958","article-title":"Hepatitis E virus infection as a cause of graft hepatitis in liver transplant recipients.","volume":"16","author":"Pischke","year":"2010","journal-title":"Liver Transpl"},{"key":"R46-4-20250124","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/lt.21925","article-title":"Are recipients of solid organ transplantation a highrisk population for hepatitis E virus infection?","volume":"16","author":"Buti","year":"2010","journal-title":"Liver Transpl"},{"key":"RU47-4-20250124","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1053\/j.gastro.2011.02.050","article-title":"Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants.","volume":"140","author":"Kamar","year":"2011","journal-title":"Gastroenterology"},{"key":"R48-4-20250124","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1136\/gutjnl-2011-300708","article-title":"Chronic hepatitis E infection in children with liver transplantation.","volume":"61","author":"Halac","year":"2012","journal-title":"Gut"},{"key":"R49-4-20250124","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1111\/j.1600-6143.2008.02286.x","article-title":"Hepatitis E virusrelated cirrhosis in kidney and kidneypancreastransplant recipients.","volume":"8","author":"Kamar","year":"2008","journal-title":"Am J Transplant"},{"key":"R50-4-20250124","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1056\/NEJMc0708687","article-title":"Chronic hepatitis E with cirrhosis in a kidneytransplant recipient.","volume":"358","author":"Gerolami","year":"2008","journal-title":"N Engl J Med"},{"key":"R51-4-20250124","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/lt.21926","article-title":"Reply: are recipients of solid organ transplantation a highrisk population for hepatitis E virus infection?","volume":"16","author":"Haagsma","year":"2010","journal-title":"Liver Transpl"},{"key":"R52-4-20250124","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1128\/CVI.00255-06","article-title":"Communitybased seroepidemiological survey of hepatitis E virus infection in Catalonia, Spain.","volume":"13","author":"Buti","year":"2006","journal-title":"Clin Vaccine Immunol"},{"key":"R53-4-20250124","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1002\/lt.21819","article-title":"Prevalence of hepatitis E virus infection in liver transplant recipients.","volume":"15","author":"Haagsma","year":"2009","journal-title":"Liver Transpl"},{"key":"R54-4-20250124","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.jhep.2011.06.021","article-title":"Liver transplant from a donor with occult HEV infection induced chronic hepatitis and cirrhosis in the recipient.","volume":"56","author":"Schlosser","year":"2012","journal-title":"J Hepatol"},{"key":"R55-4-20250124","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/hep.24738","article-title":"Hepatitis E virus (HEV)specific Tcell responses are associated with control of HEV infection.","volume":"55","author":"Suneetha","year":"2012","journal-title":"Hepatology"},{"key":"R56-4-20250124","doi-asserted-by":"crossref","first-page":"10006","DOI":"10.1128\/JVI.01003-12","article-title":"Hepatitis E virus quasispecies and the outcome of acute hepatitis E in solidorgan transplant patients.","volume":"86","author":"Lhomme","year":"2012","journal-title":"J Virol"},{"key":"R57-4-20250124","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1111\/ajt.12253","article-title":"How should hepatitis E virus infection be defined in organtransplant recipients?","volume":"13","author":"Kamar","year":"2013","journal-title":"Am J Transplant"},{"key":"R58-4-20250124","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1056\/NEJMc080634","article-title":"Chronic hepatitis E and organ transplants.","volume":"358","author":"Schildgen","year":"2008","journal-title":"N Engl J Med"},{"key":"R59-4-20250124","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1002\/hep.25530","article-title":"Suppression of interferon signaling by hepatitis E virus.","volume":"55","author":"Dong","year":"2012","journal-title":"Hepatology"},{"key":"R60-4-20250124","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1086\/650488","article-title":"Pegylated interferonalpha for treating chronic hepatitis E virus infection after liver transplantation.","volume":"50","author":"Kamar","year":"2010","journal-title":"Clin Infect Dis"},{"key":"R61-4-20250124","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/lt.22014","article-title":"Treatment of chronic hepatitis E in liver transplant recipients with pegylated interferon alpha2b.","volume":"16","author":"Haagsma","year":"2010","journal-title":"Liver Transpl"},{"key":"R62-4-20250124","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/liv.12114","article-title":"Ribavirin treatment of acute and chronic hepatitis E: a singlecentre experience.","volume":"33","author":"Pischke","year":"2013","journal-title":"Liver Int"},{"key":"RU63-4-20250124","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/petr.12077","article-title":"Results of singlecenter screening for chronic hepatitis E in children after liver transplantation and report on successful treatment with ribavirin.","volume":"17","author":"Junge","year":"2013","journal-title":"Pediatr Transplant"},{"key":"R64-4-20250124","doi-asserted-by":"crossref","first-page":"85","DOI":"10.7326\/0003-4819-153-2-201007200-00257","article-title":"Brief communication: case reports of ribavirin treatment for chronic hepatitis E.","volume":"153","author":"Mallet","year":"2010","journal-title":"Ann Intern Med"},{"key":"R65-4-20250124","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1053\/j.gastro.2010.08.002","article-title":"Ribavirin therapy inhibits viral replication on patients with chronic hepatitis E virus infection.","volume":"139","author":"Kamar","year":"2010","journal-title":"Gastroenterology"},{"key":"R66-4-20250124","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jcv.2011.06.004","article-title":"Treatment of severe acute hepatitis E by ribavirin.","volume":"52","author":"Gerolami","year":"2011","journal-title":"J Clin Virol"},{"key":"R67-4-20250124","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.healun.2012.11.027","article-title":"Chronic hepatitis E infection in lung transplant recipients.","volume":"32","author":"RiezebosBrilman","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"R68-4-20250124","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.healun.2011.03.013","article-title":"Sustained virologic response with ribavirin in chronic hepatitis E virus infection in heart transplantation.","volume":"30","author":"Chaillon","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"R69-4-20250124","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1111\/j.1600-6143.2012.04200.x","article-title":"Chronic hepatitis E in heart transplant recipients.","volume":"12","author":"Pischke","year":"2012","journal-title":"Am J Transplant"}],"container-title":["Liver Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Flt.23764","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/lt.23764","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/lt.23764","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01445473-201401000-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T17:24:16Z","timestamp":1737739456000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01445473-201401000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":67,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1002\/lt.23764","relation":{},"ISSN":["1527-6465"],"issn-type":[{"value":"1527-6465","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]}}}